lonafarnib has been researched along with cysmethynil in 1 studies
| Studies (lonafarnib) | Trials (lonafarnib) | Recent Studies (post-2010) (lonafarnib) | Studies (cysmethynil) | Trials (cysmethynil) | Recent Studies (post-2010) (cysmethynil) |
|---|---|---|---|---|---|
| 224 | 34 | 90 | 18 | 0 | 12 |
| Protein | Taxonomy | lonafarnib (IC50) | cysmethynil (IC50) |
|---|---|---|---|
| Protein-S-isoprenylcysteine O-methyltransferase | Homo sapiens (human) | 2.0579 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar-Garrido, P; Balabasquer, M; Campillo, M; Cushman, I; Gajate, C; Gallardo, M; Gil-Ordóñez, A; López-Rodríguez, ML; Marcos-Ramiro, B; Marín-Ramos, NI; Martín-Fontecha, M; Medrano, FJ; Mollinedo, F; Ortega-Gutiérrez, S; Ortega-Nogales, FJ; Philips, MR; Romero, A; Torrecillas, IR | 1 |
1 other study(ies) available for lonafarnib and cysmethynil
| Article | Year |
|---|---|
A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia.
Topics: Alanine; Amides; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Mice; Protein Methyltransferases; Xenograft Model Antitumor Assays | 2019 |